Novavax Inc (NVAX)

Cost of Revenue

$91.64M

TTM · Period ending: · USD

NVAX logo

NVAX Cost of Revenue

Latest reported$91.64M
NVAX TTM Cost of Revenue (-$400.00K → $91.64M)
High-resolution chart · PNG

NVAX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Novavax Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
91,641,000
91,620,000
75,040,000
86,505,000
125,628,000
157,645,000
192,339,000
304,546,000
342,856,000
352,391,000
337,668,000
370,557,000
706,221,000
921,521,000
902,639,000
720,874,000
286,281,000
15,204,000
0
0
0
0
0
0
0
0
0
0
0
0
0
49,656,000
49,656,000
49,656,000
49,656,000
51,100,000
51,100,000
51,100,000
51,100,000
7,893,000
10,640,000
13,327,000
15,786,000
10,730,000
12,010,000
14,425,000
14,987,000
14,753,000
13,002,000
9,532,000
8,223,000
7,572,000
9,134,000
12,620,000
14,694,000
19,745,000
15,907,000
10,789,000
7,003,000
0
0
0
0
0
0
0
0
0
0
0
0
-3,048,000
-1,952,000
-1,097,000
307,000
6,264,000
6,338,000
6,644,000
6,788,000
4,596,000
4,494,000
5,360,000
5,791,000
6,436,000
5,732,000
5,206,000
3,490,000
2,801,000
3,198,000
2,085,000
2,056,000
2,114,000
2,115,000
2,735,000
3,558,000
3,953,000
4,013,000
4,066,000
4,052,000
2,641,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.